Supplementary Figure 3 from Ex Vivo Efficacy of SAR442257 Anti-CD38 Trispecific T-cell Engager in Multiple Myeloma Relapsed After Daratumumab and BCMA-targeted Therapies
Published in 2024 by
Alana L. Keller,
Lauren T. Reiman 
,
Olivia Perez de Acha ,
Sarah E. Parzych ,
Peter A. Forsberg,
Peter S. Kim,
Kamlesh Bisht ,
Hongfang Wang,
Helgi van de Velde,
Daniel W. Sherbenou
,
Olivia Perez de Acha ,
Sarah E. Parzych ,
Peter A. Forsberg,
Peter S. Kim,
Kamlesh Bisht ,
Hongfang Wang,
Helgi van de Velde,
Daniel W. Sherbenou
